Review



vaxarray analysis software v2.2  (InDevR Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    InDevR Inc vaxarray analysis software v2.2
    Design of <t>VaxArray</t> pneumococcal assay. ( a ) Schematic representation of the VaxArray pneumococcal assay kit microarray slide showing 16 replicate microarrays, A1-H2 represents the location of each microarray; ( b ) individual microarray layout showing 3 replicate spots for each serotype, with fiducial markers in grey at top and bottom; and ( c ) general assay detection scheme showing serotype-specific capture with primary detection and fluorescent secondary detection label. The primary label can either target polysaccharide or CRM197 carrier protein. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article).
    Vaxarray Analysis Software V2.2, supplied by InDevR Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vaxarray analysis software v2.2/product/InDevR Inc
    Average 90 stars, based on 1 article reviews
    vaxarray analysis software v2.2 - by Bioz Stars, 2026-04
    90/100 stars

    Images

    1) Product Images from "30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization"

    Article Title: 30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization

    Journal: Vaccines

    doi: 10.3390/vaccines10111964

    Design of VaxArray pneumococcal assay. ( a ) Schematic representation of the VaxArray pneumococcal assay kit microarray slide showing 16 replicate microarrays, A1-H2 represents the location of each microarray; ( b ) individual microarray layout showing 3 replicate spots for each serotype, with fiducial markers in grey at top and bottom; and ( c ) general assay detection scheme showing serotype-specific capture with primary detection and fluorescent secondary detection label. The primary label can either target polysaccharide or CRM197 carrier protein. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article).
    Figure Legend Snippet: Design of VaxArray pneumococcal assay. ( a ) Schematic representation of the VaxArray pneumococcal assay kit microarray slide showing 16 replicate microarrays, A1-H2 represents the location of each microarray; ( b ) individual microarray layout showing 3 replicate spots for each serotype, with fiducial markers in grey at top and bottom; and ( c ) general assay detection scheme showing serotype-specific capture with primary detection and fluorescent secondary detection label. The primary label can either target polysaccharide or CRM197 carrier protein. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article).

    Techniques Used: Microarray

    Representative fluorescence microarray images demonstrating reactivity and specificity of the VaxArray pneumococcal assay after the incubation of 2 µg/mL monovalent Pfizer native PS serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 8, 9N, 9V, 10A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F (ATCC, deposited by Pfizer); a no antigen blank; and a 23-valent mixture containing all serotypes mentioned above.
    Figure Legend Snippet: Representative fluorescence microarray images demonstrating reactivity and specificity of the VaxArray pneumococcal assay after the incubation of 2 µg/mL monovalent Pfizer native PS serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 8, 9N, 9V, 10A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F (ATCC, deposited by Pfizer); a no antigen blank; and a 23-valent mixture containing all serotypes mentioned above.

    Techniques Used: Fluorescence, Microarray, Incubation

    Native PS reactivity. Signal-to-blank ratios (S/Bl) on the VaxArray 23-valent pneumococcal assay for Pfizer native PS materials (ATCC, deposited by Pfizer) at 2 µg/mL; columns represent each serotype-specific capture antibody, and rows represent each serotype of native PS tested. Text in bold green shows S/Bl ≥ 3 generated for the matched PS and capture antibody. Text in bold black shows S/Bl ≥ 3 generated on off-target capture antibody indicating cross-reactivity.
    Figure Legend Snippet: Native PS reactivity. Signal-to-blank ratios (S/Bl) on the VaxArray 23-valent pneumococcal assay for Pfizer native PS materials (ATCC, deposited by Pfizer) at 2 µg/mL; columns represent each serotype-specific capture antibody, and rows represent each serotype of native PS tested. Text in bold green shows S/Bl ≥ 3 generated for the matched PS and capture antibody. Text in bold black shows S/Bl ≥ 3 generated on off-target capture antibody indicating cross-reactivity.

    Techniques Used: Generated, Microarray

    Signal correlation between anthrone and VaxArray assays. ( a ) Signal response correlation for S6A native PS from EuBiologics (EuB). The same serial dilution evaluated by the anthrone assay was diluted 100- to 200-fold to perform VaxArray assay due to VaxArray assay sensitivity. Error bars indicate ± 1 standard deviation (n = 3). ( b ) Precision (%RSD) for anthrone and VaxArray assays and associated R2 value for signal correlation of each sample (n = 3 for each concentration of each method).
    Figure Legend Snippet: Signal correlation between anthrone and VaxArray assays. ( a ) Signal response correlation for S6A native PS from EuBiologics (EuB). The same serial dilution evaluated by the anthrone assay was diluted 100- to 200-fold to perform VaxArray assay due to VaxArray assay sensitivity. Error bars indicate ± 1 standard deviation (n = 3). ( b ) Precision (%RSD) for anthrone and VaxArray assays and associated R2 value for signal correlation of each sample (n = 3 for each concentration of each method).

    Techniques Used: Serial Dilution, Standard Deviation, Concentration Assay



    Similar Products

    vaxarray analysis software v2.2  (InDevR Inc)
    90
    InDevR Inc vaxarray analysis software v2.2
    Design of <t>VaxArray</t> pneumococcal assay. ( a ) Schematic representation of the VaxArray pneumococcal assay kit microarray slide showing 16 replicate microarrays, A1-H2 represents the location of each microarray; ( b ) individual microarray layout showing 3 replicate spots for each serotype, with fiducial markers in grey at top and bottom; and ( c ) general assay detection scheme showing serotype-specific capture with primary detection and fluorescent secondary detection label. The primary label can either target polysaccharide or CRM197 carrier protein. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article).
    Vaxarray Analysis Software V2.2, supplied by InDevR Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vaxarray analysis software v2.2/product/InDevR Inc
    Average 90 stars, based on 1 article reviews
    vaxarray analysis software v2.2 - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier
    vaxarray analysis software  (InDevR Inc)
    90
    InDevR Inc vaxarray analysis software
    Design of <t>VaxArray</t> Pneumococcal Assay. (a) Schematic representation of the VaxArray Pneumococcal Assay Kit microarray slide showing 16 replicate microarrays, (b) individual microarray layout showing 3 replicate spots for each serotype, and fiducial markers in grey at top and bottom, (c) general assay detection scheme showing serotype-specific capture with primary detection and fluorescent secondary detection label. The primary label can either target polysaccharide or CRM197 carrier protein. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
    Vaxarray Analysis Software, supplied by InDevR Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vaxarray analysis software/product/InDevR Inc
    Average 90 stars, based on 1 article reviews
    vaxarray analysis software - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Design of VaxArray pneumococcal assay. ( a ) Schematic representation of the VaxArray pneumococcal assay kit microarray slide showing 16 replicate microarrays, A1-H2 represents the location of each microarray; ( b ) individual microarray layout showing 3 replicate spots for each serotype, with fiducial markers in grey at top and bottom; and ( c ) general assay detection scheme showing serotype-specific capture with primary detection and fluorescent secondary detection label. The primary label can either target polysaccharide or CRM197 carrier protein. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article).

    Journal: Vaccines

    Article Title: 30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization

    doi: 10.3390/vaccines10111964

    Figure Lengend Snippet: Design of VaxArray pneumococcal assay. ( a ) Schematic representation of the VaxArray pneumococcal assay kit microarray slide showing 16 replicate microarrays, A1-H2 represents the location of each microarray; ( b ) individual microarray layout showing 3 replicate spots for each serotype, with fiducial markers in grey at top and bottom; and ( c ) general assay detection scheme showing serotype-specific capture with primary detection and fluorescent secondary detection label. The primary label can either target polysaccharide or CRM197 carrier protein. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article).

    Article Snippet: Slides were dried and imaged using the VaxArray Imaging System (VX-6000, InDevR Inc.), and images were processed using the VaxArray Analysis Software (v2.2, InDevR Inc).

    Techniques: Microarray

    Representative fluorescence microarray images demonstrating reactivity and specificity of the VaxArray pneumococcal assay after the incubation of 2 µg/mL monovalent Pfizer native PS serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 8, 9N, 9V, 10A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F (ATCC, deposited by Pfizer); a no antigen blank; and a 23-valent mixture containing all serotypes mentioned above.

    Journal: Vaccines

    Article Title: 30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization

    doi: 10.3390/vaccines10111964

    Figure Lengend Snippet: Representative fluorescence microarray images demonstrating reactivity and specificity of the VaxArray pneumococcal assay after the incubation of 2 µg/mL monovalent Pfizer native PS serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 8, 9N, 9V, 10A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F (ATCC, deposited by Pfizer); a no antigen blank; and a 23-valent mixture containing all serotypes mentioned above.

    Article Snippet: Slides were dried and imaged using the VaxArray Imaging System (VX-6000, InDevR Inc.), and images were processed using the VaxArray Analysis Software (v2.2, InDevR Inc).

    Techniques: Fluorescence, Microarray, Incubation

    Native PS reactivity. Signal-to-blank ratios (S/Bl) on the VaxArray 23-valent pneumococcal assay for Pfizer native PS materials (ATCC, deposited by Pfizer) at 2 µg/mL; columns represent each serotype-specific capture antibody, and rows represent each serotype of native PS tested. Text in bold green shows S/Bl ≥ 3 generated for the matched PS and capture antibody. Text in bold black shows S/Bl ≥ 3 generated on off-target capture antibody indicating cross-reactivity.

    Journal: Vaccines

    Article Title: 30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization

    doi: 10.3390/vaccines10111964

    Figure Lengend Snippet: Native PS reactivity. Signal-to-blank ratios (S/Bl) on the VaxArray 23-valent pneumococcal assay for Pfizer native PS materials (ATCC, deposited by Pfizer) at 2 µg/mL; columns represent each serotype-specific capture antibody, and rows represent each serotype of native PS tested. Text in bold green shows S/Bl ≥ 3 generated for the matched PS and capture antibody. Text in bold black shows S/Bl ≥ 3 generated on off-target capture antibody indicating cross-reactivity.

    Article Snippet: Slides were dried and imaged using the VaxArray Imaging System (VX-6000, InDevR Inc.), and images were processed using the VaxArray Analysis Software (v2.2, InDevR Inc).

    Techniques: Generated, Microarray

    Signal correlation between anthrone and VaxArray assays. ( a ) Signal response correlation for S6A native PS from EuBiologics (EuB). The same serial dilution evaluated by the anthrone assay was diluted 100- to 200-fold to perform VaxArray assay due to VaxArray assay sensitivity. Error bars indicate ± 1 standard deviation (n = 3). ( b ) Precision (%RSD) for anthrone and VaxArray assays and associated R2 value for signal correlation of each sample (n = 3 for each concentration of each method).

    Journal: Vaccines

    Article Title: 30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization

    doi: 10.3390/vaccines10111964

    Figure Lengend Snippet: Signal correlation between anthrone and VaxArray assays. ( a ) Signal response correlation for S6A native PS from EuBiologics (EuB). The same serial dilution evaluated by the anthrone assay was diluted 100- to 200-fold to perform VaxArray assay due to VaxArray assay sensitivity. Error bars indicate ± 1 standard deviation (n = 3). ( b ) Precision (%RSD) for anthrone and VaxArray assays and associated R2 value for signal correlation of each sample (n = 3 for each concentration of each method).

    Article Snippet: Slides were dried and imaged using the VaxArray Imaging System (VX-6000, InDevR Inc.), and images were processed using the VaxArray Analysis Software (v2.2, InDevR Inc).

    Techniques: Serial Dilution, Standard Deviation, Concentration Assay

    Design of VaxArray Pneumococcal Assay. (a) Schematic representation of the VaxArray Pneumococcal Assay Kit microarray slide showing 16 replicate microarrays, (b) individual microarray layout showing 3 replicate spots for each serotype, and fiducial markers in grey at top and bottom, (c) general assay detection scheme showing serotype-specific capture with primary detection and fluorescent secondary detection label. The primary label can either target polysaccharide or CRM197 carrier protein. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

    Journal: bioRxiv

    Article Title: 30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization

    doi: 10.1101/2022.09.28.509947

    Figure Lengend Snippet: Design of VaxArray Pneumococcal Assay. (a) Schematic representation of the VaxArray Pneumococcal Assay Kit microarray slide showing 16 replicate microarrays, (b) individual microarray layout showing 3 replicate spots for each serotype, and fiducial markers in grey at top and bottom, (c) general assay detection scheme showing serotype-specific capture with primary detection and fluorescent secondary detection label. The primary label can either target polysaccharide or CRM197 carrier protein. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

    Article Snippet: Slides were dried and imaged using the VaxArray Imaging System (VX-6000, InDevR Inc.), and images processed using the VaxArray Analysis Software.

    Techniques: Microarray

    Representative fluorescence microarray images demonstrating reactivity and specificity of the VaxArray Pneumococcal Assay after the incubation of 2 µg/mL monovalent Pfizer native PS serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 8, 9N, 9V, 10A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, 33F (ATCC, deposited by Pfizer), a no antigen blank, and a 23-valent mixture containing all serotypes mentioned above.

    Journal: bioRxiv

    Article Title: 30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization

    doi: 10.1101/2022.09.28.509947

    Figure Lengend Snippet: Representative fluorescence microarray images demonstrating reactivity and specificity of the VaxArray Pneumococcal Assay after the incubation of 2 µg/mL monovalent Pfizer native PS serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 8, 9N, 9V, 10A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, 33F (ATCC, deposited by Pfizer), a no antigen blank, and a 23-valent mixture containing all serotypes mentioned above.

    Article Snippet: Slides were dried and imaged using the VaxArray Imaging System (VX-6000, InDevR Inc.), and images processed using the VaxArray Analysis Software.

    Techniques: Fluorescence, Microarray, Incubation

    Journal: bioRxiv

    Article Title: 30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization

    doi: 10.1101/2022.09.28.509947

    Figure Lengend Snippet:

    Article Snippet: Slides were dried and imaged using the VaxArray Imaging System (VX-6000, InDevR Inc.), and images processed using the VaxArray Analysis Software.

    Techniques: Generated

    Signal correlation between anthrone and VaxArray assays. a) Signal response correlation for S6A native PS from EuBiologics (EuB). Same serial dilution evaluated by the anthrone assay was diluted 100 to 200-fold to perform VaxArray Assay due to VaxArray assay sensitivity. Error bars indicate ± 1 standard deviation (n=3). b) Precision (%RSD) for anthrone and VaxArray assays and associated R 2 value for signal correlation of each sample (n=3 for each concentration of each method).

    Journal: bioRxiv

    Article Title: 30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization

    doi: 10.1101/2022.09.28.509947

    Figure Lengend Snippet: Signal correlation between anthrone and VaxArray assays. a) Signal response correlation for S6A native PS from EuBiologics (EuB). Same serial dilution evaluated by the anthrone assay was diluted 100 to 200-fold to perform VaxArray Assay due to VaxArray assay sensitivity. Error bars indicate ± 1 standard deviation (n=3). b) Precision (%RSD) for anthrone and VaxArray assays and associated R 2 value for signal correlation of each sample (n=3 for each concentration of each method).

    Article Snippet: Slides were dried and imaged using the VaxArray Imaging System (VX-6000, InDevR Inc.), and images processed using the VaxArray Analysis Software.

    Techniques: Serial Dilution, Standard Deviation, Concentration Assay